Turning teams and pathways into integrated practice units: Appearance characteristics and added value

por van Harten, WH
Publicado 2018

Innovations that reach the patient: early health technology assessment and improving the chances of coverage and implementation

por van Harten, WH, Retèl, VP
Publicado 2016

Close cooperation with Health Technology Assessment expertise is crucial for implementation and ultimately reimbursement of innovations in oncology

por van Harten, WH, Retèl, VP
Publicado 2016

Scenario drafting for early technology assessment of next generation sequencing in clinical oncology

por Joosten, S.E.P., Retèl, V.P., Coupé, V.M.H., van den Heuvel, M.M., van Harten, W.H.
Publicado 2016

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study

por Drukker, CA, Bueno-de-Mesquita, JM, Retèl, VP, van Harten, WH, van Tinteren, H, Wesseling, J, Roumen, RMH, Knauer, M, van 't Veer, LJ, Sonke, GS, Rutgers, EJT, van de Vijver, MJ, Linn, SC
Publicado 2013

Excellent translational research in oncology: A journey towards novel and more effective anti‐cancer therapies

por Rajan, A., Berns, A., Ringborg, U., Celis, J., Ponder, B., Caldas, C., Livingston, D., Bristow, R.G., Hecht, T.T., Tursz, T., van Luenen, H., Bono, P., Helander, T., Seamon, K., Smyth, J.F., Louvard, D., Eggermont, A., van Harten, W.H.
Publicado 2015

Report from the OECI Oncology Days 2014

por van Harten, WH, Stanta, G, Bussolati, G, Riegman, P, Hoefler, G, Becker, KF, Folprecht, G, Truini, M, Haybaeck, J, Buiga, R, Dono, M, Bagg, A, López Guerrero, JA, Zupo, S, Lemare, F, de Lorenzo, F, Goedbloed, N, Razavi, D, Lövey, J, Cadariu, PA, Rollandi, GA, Paparo, F, Pierotti, M, Ciuleanu, T, De Paoli, P, Weiner, G, Saghatchian, M, Lombardo, Claudio
Publicado 2014